In Featured, News by Ged Kenslea
December 21, 2020
Amgen joined eight other rogue drug companies by
declaring last week that it will refuse to sell ‘orphan drugs’ (expensive drugs for rare diseases) at the legally required ‘340B price’
as required by section 340B of the U.S. Public Health Services Act
Refusals are tone-deaf moves by obscenely wealthy drug companies during height of coronavirus pandemic
WASHINGTON (December 21, 2020) AIDS Healthcare Foundation (AHF) will host a socially distant protest and car caravan targeting Amgen for its announced refusal to sell so-called “orphan drugs’ at reduced prices to nonprofit providers who are covered entities under the 340B Drug Discount Program. The protest will take place Tuesday, December 22 from 11am to 12noon at Amgen’s corporate headquarters (1100 Rancho Conejo Blvd, Thousand Oaks, CA 91320).